Johnson & Johnson to Acquire Firefly Bio for $1 Billion

Included Health to Acquire Firefly Health

July 28, 2026

Healthcare Services

Included Health signed a definitive agreement to acquire Firefly Health, a clinically-integrated health plan and advanced primary care provider. The companies plan to combine Included Health’s AI-native navigation and clinical platform with Firefly’s NCQA-accredited primary care model, dynamic benefit design, and a nationwide network of 2,300+ care partners to deliver a scalable alternative health plan for employers. The transaction is expected to close in Q3 2026, subject to regulatory review.

Eli Lilly & Company Acquires CrossBridge Bio

April 14, 2026

Biotechnology

Eli Lilly and Company has entered into a definitive agreement to acquire CrossBridge Bio, a Houston-based pre-clinical biotechnology company developing next-generation dual-payload antibody-drug conjugates (ADCs). The deal provides for up to $300 million in total consideration, including upfront and milestone-based payments, to advance CrossBridge Bio’s TROP2-targeting TOP1i/ATRi ADC platform led by CBB-120.

Johnson & Johnson to Acquire Ambrx Biopharma in ~$2 Billion All-Cash Deal

January 8, 2024

Pharmaceuticals

Johnson & Johnson announced it has entered into a definitive agreement to acquire Ambrx Biopharma in an all-cash merger transaction valued at about $2 billion (about $1.9 billion net of estimated cash acquired). The deal is intended to add Ambrx’s proprietary synthetic biology and ADC (antibody-drug conjugate) technology platform and its clinical and preclinical oncology pipeline to J&J’s targeted oncology therapeutics efforts.

CloudScale365 Acquires Firefly IT Services, Inc.

October 3, 2023

IT Services

CloudScale365, a U.S. managed IT services provider, has acquired Firefly IT Services, a Sacramento-based regional network and systems management firm. The acquisition expands CloudScale365's presence in Northern California and adds Firefly's 25 years of network expertise and local engineering, security, and application-support capabilities to its platform.

Veracross Acquires Firefly Learning

February 7, 2023

Education

Veracross has acquired Firefly Learning, a UK-based student behavior and engagement platform focused on K-12 schools. The acquisition brings together complementary K-12 products to expand Veracross's offering and enable cross-market expansion while preserving Firefly's integrations with other MIS/SIS providers.

Merck & Co., Inc. Acquires VelosBio Inc.

November 5, 2020

Biotechnology

Merck & Co., Inc. will acquire all outstanding shares of clinical-stage biopharmaceutical company VelosBio for $2.75 billion in cash. The acquisition adds VelosBio's lead investigational antibody-drug conjugate VLS-101 and ROR1-directed pipeline assets to Merck's oncology portfolio and is expected to close by the end of 2020, subject to customary conditions.